Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 104

1.

Characterizing trends in treatment modalities for localized muscle-invasive bladder cancer in the pre-immunotherapy era.

Fletcher SA, Harmouch SS, Krimphove MJ, Cole AP, Berg S, Gild P, Preston MA, Sonpavde GP, Kibel AS, Sun M, Choueiri TK, Trinh QD.

World J Urol. 2018 Jun 14. doi: 10.1007/s00345-018-2371-y. [Epub ahead of print]

PMID:
29948050
2.

Corrigendum re "Genetic Variants Related to Longer Telomere Length are Associated with Increased Risk of Renal Cell Carcinoma" [Eur Urol 2017;72:747-54].

Machiela MJ, Hofmann JN, Carreras-Torres R, Brown KM, Johansson M, Wang Z, Foll M, Li P, Rothman N, Savage SA, Gaborieau V, McKay JD, Ye Y, Henrion M, Bruinsma F, Jordan S, Severi G, Hveem K, Vatten LJ, Fletcher T, Koppova K, Larsson SC, Wolk A, Banks RE, Selby PJ, Easton DF, Pharoah P, Andreotti G, Freeman LEB, Koutros S, Albanes D, Mannisto S, Weinstein S, Clark PE, Edwards TE, Lipworth L, Gapstur SM, Stevens VL, Carol H, Freedman ML, Pomerantz MM, Cho E, Kraft P, Preston MA, Wilson KM, Gaziano JM, Sesso HS, Black A, Freedman ND, Huang WY, Anema JG, Kahnoski RJ, Lane BR, Noyes SL, Petillo D, Colli LM, Sampson JN, Besse C, Blanche H, Boland A, Burdette L, Prokhortchouk E, Skryabin KG, Yeager M, Mijuskovic M, Ognjanovic M, Foretova L, Holcatova I, Janout V, Mates D, Mukeriya A, Rascu S, Zaridze D, Bencko V, Cybulski C, Fabianova E, Jinga V, Lissowska J, Lubinski J, Navratilova M, Rudnai P, Szeszenia-Dabrowska N, Benhamou S, Cancel-Tassin G, Cussenot O, Bueno-de-Mesquita HBA, Canzian F, Duell EJ, Ljungberg B, Sitaram RT, Peters U, White E, Anderson GL, Johnson L, Luo J, Buring J, Lee IM, Chow WH, Moore LE, Wood C, Eisen T, Larkin J, Choueiri TK, Lathrop GM, Teh BT, Deleuze JF, Wu X, Houlston RS, Brennan P, Chanock SJ, Scelo G, Purdue MP.

Eur Urol. 2018 May 28. pii: S0302-2838(18)30366-X. doi: 10.1016/j.eururo.2018.05.017. [Epub ahead of print] No abstract available.

PMID:
29853305
3.

Dietary Acrylamide Intake and Risk of Renal Cell Carcinoma in Two Large Prospective Cohorts.

Graff RE, Cho E, Preston MA, Sanchez A, Mucci LA, Wilson KM.

Cancer Epidemiol Biomarkers Prev. 2018 May 14. doi: 10.1158/1055-9965.EPI-18-0320. [Epub ahead of print]

PMID:
29760239
4.

Type 2 Diabetes in Relation to the Risk of Renal Cell Carcinoma Among Men and Women in Two Large Prospective Cohort Studies.

Graff RE, Sanchez A, Tobias DK, Rodríguez D, Barrisford GW, Blute ML, Li Y, Sun Q, Preston MA, Wilson KM, Cho E.

Diabetes Care. 2018 Jul;41(7):1432-1437. doi: 10.2337/dc17-2518. Epub 2018 Apr 20.

PMID:
29678810
5.

Insurance coverage mandates: Impact of physician utilization in moderating colorectal cancer screening rates.

Preston MA, Mays GP, Bursac Z, Thomas BR, Laryea J, Tilford JM, Odlum M, Smith SA, Henry-Tillman RS.

Am J Surg. 2018 Jun;215(6):1004-1010. doi: 10.1016/j.amjsurg.2018.02.026. Epub 2018 Mar 2.

PMID:
29555083
6.

The effect of treatment at minority-serving hospitals on outcomes for bladder cancer.

Fletcher SA, Gild P, Cole AP, Vetterlein MW, Kibel AS, Choueiri TK, Sonpavde GP, Preston MA, Pucheril D, Menon M, Sun M, Lipsitz SR, Trinh QD.

Urol Oncol. 2018 May;36(5):238.e7-238.e17. doi: 10.1016/j.urolonc.2018.01.010. Epub 2018 Feb 15.

PMID:
29454591
7.

Reply to Christian D. Fankhauser, Nico C. Grossmann, Joerg Beyer, and Thomas Hermanns' Letter to the Editor re: Sophia C. Kamran, Thomas Seisen, Sarah C. Markt, et al. Contemporary Treatment Patterns and Outcomes for Clinical Stage IS Testicular Cancer. Eur Urol 2018;73:262-70.

Kamran SC, Seisen T, Markt SC, Preston MA, Trinh QD, Frazier LA, Choueiri TK, Martin NE, Nguyen PL, Beard CJ.

Eur Urol. 2018 Apr;73(4):e96-e97. doi: 10.1016/j.eururo.2017.12.026. Epub 2018 Jan 19. No abstract available.

PMID:
29358058
8.

Bladder cancer local staging: multiparametric MRI performance following transurethral resection.

van der Pol CB, Shinagare AB, Tirumani SH, Preston MA, Vangel MG, Silverman SG.

Abdom Radiol (NY). 2018 Jan 9. doi: 10.1007/s00261-017-1449-0. [Epub ahead of print]

PMID:
29313114
9.

Post prostatectomy outcomes of patients with high-risk prostate cancer treated with neoadjuvant androgen blockade.

McKay RR, Montgomery B, Xie W, Zhang Z, Bubley GJ, Lin DW, Preston MA, Trinh QD, Chang P, Wagner AA, Mostaghel EA, Kantoff PW, Nelson PS, Kibel AS, Taplin ME.

Prostate Cancer Prostatic Dis. 2017 Dec 20. doi: 10.1038/s41391-017-0009-6. [Epub ahead of print]

PMID:
29263420
10.

Reply to Aditya Bagrodia, Solomon Woldu, David F. Penson, Alexander Kutikov, and Samuel D. Kaffenberger's Letter to the Editor re: Sophia C. Kamran, Thomas Seisen, Sarah C. Markt, et al. Contemporary Treatment Patterns and Outcomes for Clinical Stage IS Testicular Cancer. Eur Urol 2018;73:262-70.

Seisen T, Kamran SC, Markt SC, Preston MA, Trinh QD, Frazier LA, Choueiri TK, Martin NE, Nguyen PL, Beard CJ.

Eur Urol. 2018 Apr;73(4):e100-e101. doi: 10.1016/j.eururo.2017.10.013. Epub 2017 Nov 3. No abstract available.

PMID:
29108659
11.

Associations of specific postoperative complications with costs after radical cystectomy.

Mossanen M, Krasnow RE, Lipsitz SR, Preston MA, Kibel AS, Ha A, Gore JL, Smith AB, Leow JJ, Trinh QD, Chang SL.

BJU Int. 2018 Mar;121(3):428-436. doi: 10.1111/bju.14064. Epub 2017 Nov 16.

PMID:
29063725
12.

Bladder Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology.

Spiess PE, Agarwal N, Bangs R, Boorjian SA, Buyyounouski MK, Clark PE, Downs TM, Efstathiou JA, Flaig TW, Friedlander T, Greenberg RE, Guru KA, Hahn N, Herr HW, Hoimes C, Inman BA, Jimbo M, Kader AK, Lele SM, Meeks JJ, Michalski J, Montgomery JS, Pagliaro LC, Pal SK, Patterson A, Plimack ER, Pohar KS, Porter MP, Preston MA, Sexton WJ, Siefker-Radtke AO, Sonpavde G, Tward J, Wile G, Dwyer MA, Gurski LA.

J Natl Compr Canc Netw. 2017 Oct;15(10):1240-1267. doi: 10.6004/jnccn.2017.0156.

PMID:
28982750
13.

Effect of Nonurothelial Histologic Variants on the Outcomes of Radical Cystectomy for Nonmetastatic Muscle-invasive Urinary Bladder Cancer.

Vetterlein MW, Seisen T, Leow JJ, Preston MA, Sun M, Friedlander DF, Meyer CP, Chun FK, Lipsitz SR, Menon M, Kibel AS, Bellmunt J, Choueiri TK, Trinh QD.

Clin Genitourin Cancer. 2017 Aug 24. pii: S1558-7673(17)30248-3. doi: 10.1016/j.clgc.2017.08.007. [Epub ahead of print]

PMID:
28899722
14.

Quality Improvement Efforts in Radical Cystectomy: From Prehab to Rehab.

Mossanen M, Preston MA.

Eur Urol. 2017 Aug 31. pii: S0302-2838(17)30710-8. doi: 10.1016/j.eururo.2017.08.017. [Epub ahead of print] No abstract available.

PMID:
28867447
15.

Colorectal cancer screening in rural and poor-resourced communities.

Preston MA, Glover-Collins K, Ross L, Porter A, Bursac Z, Woods D, Burton J, Crowell K, Laryea J, Henry-Tillman RS.

Am J Surg. 2017 Aug 12. pii: S0002-9610(17)30452-X. doi: 10.1016/j.amjsurg.2017.08.004. [Epub ahead of print]

PMID:
28842164
16.

Variations in the Costs of Radical Cystectomy for Bladder Cancer in the USA.

Leow JJ, Cole AP, Seisen T, Bellmunt J, Mossanen M, Menon M, Preston MA, Choueiri TK, Kibel AS, Chung BI, Sun M, Chang SL, Trinh QD.

Eur Urol. 2017 Aug 9. pii: S0302-2838(17)30640-1. doi: 10.1016/j.eururo.2017.07.016. [Epub ahead of print]

PMID:
28803034
17.

Genetic Variants Related to Longer Telomere Length are Associated with Increased Risk of Renal Cell Carcinoma.

Machiela MJ, Hofmann JN, Carreras-Torres R, Brown KM, Johansson M, Wang Z, Foll M, Li P, Rothman N, Savage SA, Gaborieau V, McKay JD, Ye Y, Henrion M, Bruinsma F, Jordan S, Severi G, Hveem K, Vatten LJ, Fletcher T, Koppova K, Larsson SC, Wolk A, Banks RE, Selby PJ, Easton DF, Pharoah P, Andreotti G, Freeman LEB, Koutros S, Albanes D, Mannisto S, Weinstein S, Clark PE, Edwards TE, Lipworth L, Gapstur SM, Stevens VL, Carol H, Freedman ML, Pomerantz MM, Cho E, Kraft P, Preston MA, Wilson KM, Gaziano JM, Sesso HS, Black A, Freedman ND, Huang WY, Anema JG, Kahnoski RJ, Lane BR, Noyes SL, Petillo D, Colli LM, Sampson JN, Besse C, Blanche H, Boland A, Burdette L, Prokhortchouk E, Skryabin KG, Yeager M, Mijuskovic M, Ognjanovic M, Foretova L, Holcatova I, Janout V, Mates D, Mukeriya A, Rascu S, Zaridze D, Bencko V, Cybulski C, Fabianova E, Jinga V, Lissowska J, Lubinski J, Navratilova M, Rudnai P, Szeszenia-Dabrowska N, Benhamou S, Cancel-Tassin G, Cussenot O, Bueno-de-Mesquita HB, Canzian F, Duell EJ, Ljungberg B, Sitaram RT, Peters U, White E, Anderson GL, Johnson L, Luo J, Buring J, Lee IM, Chow WH, Moore LE, Wood C, Eisen T, Larkin J, Choueiri TK, Lathrop GM, Teh BT, Deleuze JF, Wu X, Houlston RS, Brennan P, Chanock SJ, Scelo G, Purdue MP.

Eur Urol. 2017 Nov;72(5):747-754. doi: 10.1016/j.eururo.2017.07.015. Epub 2017 Aug 7. Erratum in: Eur Urol. 2018 May 28;:.

PMID:
28797570
18.

Architecture and dynamics of overlapped RNA regulatory networks.

Lapointe CP, Preston MA, Wilinski D, Saunders HAJ, Campbell ZT, Wickens M.

RNA. 2017 Nov;23(11):1636-1647. doi: 10.1261/rna.062687.117. Epub 2017 Aug 2.

PMID:
28768715
19.

Neoadjuvant chemotherapy prior to radical cystectomy for muscle-invasive bladder cancer with variant histology.

Vetterlein MW, Wankowicz SAM, Seisen T, Lander R, Löppenberg B, Chun FK, Menon M, Sun M, Barletta JA, Choueiri TK, Bellmunt J, Trinh QD, Preston MA.

Cancer. 2017 Nov 15;123(22):4346-4355. doi: 10.1002/cncr.30907. Epub 2017 Jul 25.

PMID:
28743155
20.

Contemporary Treatment Patterns and Outcomes for Clinical Stage IS Testicular Cancer.

Kamran SC, Seisen T, Markt SC, Preston MA, Trinh QD, Frazier LA, Choueiri TK, Martin NE, Nguyen PL, Beard CJ.

Eur Urol. 2018 Feb;73(2):262-270. doi: 10.1016/j.eururo.2017.06.013. Epub 2017 Jul 4.

PMID:
28687143
21.

Editorial comment.

Sonpavde G, Preston MA.

Urology. 2017 Aug;106:124. doi: 10.1016/j.urology.2017.04.050. Epub 2017 Jun 22. No abstract available.

PMID:
28648973
22.

Genome-wide association study identifies multiple risk loci for renal cell carcinoma.

Scelo G, Purdue MP, Brown KM, Johansson M, Wang Z, Eckel-Passow JE, Ye Y, Hofmann JN, Choi J, Foll M, Gaborieau V, Machiela MJ, Colli LM, Li P, Sampson JN, Abedi-Ardekani B, Besse C, Blanche H, Boland A, Burdette L, Chabrier A, Durand G, Le Calvez-Kelm F, Prokhortchouk E, Robinot N, Skryabin KG, Wozniak MB, Yeager M, Basta-Jovanovic G, Dzamic Z, Foretova L, Holcatova I, Janout V, Mates D, Mukeriya A, Rascu S, Zaridze D, Bencko V, Cybulski C, Fabianova E, Jinga V, Lissowska J, Lubinski J, Navratilova M, Rudnai P, Szeszenia-Dabrowska N, Benhamou S, Cancel-Tassin G, Cussenot O, Baglietto L, Boeing H, Khaw KT, Weiderpass E, Ljungberg B, Sitaram RT, Bruinsma F, Jordan SJ, Severi G, Winship I, Hveem K, Vatten LJ, Fletcher T, Koppova K, Larsson SC, Wolk A, Banks RE, Selby PJ, Easton DF, Pharoah P, Andreotti G, Freeman LEB, Koutros S, Albanes D, Männistö S, Weinstein S, Clark PE, Edwards TL, Lipworth L, Gapstur SM, Stevens VL, Carol H, Freedman ML, Pomerantz MM, Cho E, Kraft P, Preston MA, Wilson KM, Michael Gaziano J, Sesso HD, Black A, Freedman ND, Huang WY, Anema JG, Kahnoski RJ, Lane BR, Noyes SL, Petillo D, Teh BT, Peters U, White E, Anderson GL, Johnson L, Luo J, Buring J, Lee IM, Chow WH, Moore LE, Wood C, Eisen T, Henrion M, Larkin J, Barman P, Leibovich BC, Choueiri TK, Mark Lathrop G, Rothman N, Deleuze JF, McKay JD, Parker AS, Wu X, Houlston RS, Brennan P, Chanock SJ.

Nat Commun. 2017 Jun 9;8:15724. doi: 10.1038/ncomms15724.

23.

Comparative Effectiveness of Trimodal Therapy Versus Radical Cystectomy for Localized Muscle-invasive Urothelial Carcinoma of the Bladder.

Seisen T, Sun M, Lipsitz SR, Abdollah F, Leow JJ, Menon M, Preston MA, Harshman LC, Kibel AS, Nguyen PL, Bellmunt J, Choueiri TK, Trinh QD.

Eur Urol. 2017 Oct;72(4):483-487. doi: 10.1016/j.eururo.2017.03.038. Epub 2017 Apr 12.

PMID:
28412065
24.

Prophylactic Antibiotics and Postoperative Complications of Radical Cystectomy: A Population Based Analysis in the United States.

Krasnow RE, Mossanen M, Koo S, Kubiak DW, Preston MA, Chung BI, Kibel AS, Chang SL.

J Urol. 2017 Aug;198(2):297-304. doi: 10.1016/j.juro.2017.02.3340. Epub 2017 Mar 4.

PMID:
28267603
25.

Regular Aspirin Use and the Risk of Lethal Prostate Cancer in the Physicians' Health Study.

Downer MK, Allard CB, Preston MA, Gaziano JM, Stampfer MJ, Mucci LA, Batista JL.

Eur Urol. 2017 Nov;72(5):821-827. doi: 10.1016/j.eururo.2017.01.044. Epub 2017 Feb 8.

PMID:
28189429
26.

Editorial Comment.

Preston MA.

J Urol. 2017 Apr;197(4):1075. doi: 10.1016/j.juro.2016.10.131. Epub 2017 Jan 13. No abstract available.

PMID:
28093246
27.

Effectiveness of Adjuvant Chemotherapy After Radical Nephroureterectomy for Locally Advanced and/or Positive Regional Lymph Node Upper Tract Urothelial Carcinoma.

Seisen T, Krasnow RE, Bellmunt J, Rouprêt M, Leow JJ, Lipsitz SR, Vetterlein MW, Preston MA, Hanna N, Kibel AS, Sun M, Choueiri TK, Trinh QD, Chang SL.

J Clin Oncol. 2017 Mar 10;35(8):852-860. doi: 10.1200/JCO.2016.69.4141. Epub 2017 Jan 3.

PMID:
28045620
28.

The Quality and Utility of Surgical and Anesthetic Data at a Ugandan Regional Referral Hospital.

Tumusiime G, Was A, Preston MA, Riesel JN, Ttendo SS, Firth PG.

World J Surg. 2017 Feb;41(2):370-379. doi: 10.1007/s00268-016-3714-8.

PMID:
27658805
29.

Meat, Fish, Poultry, and Egg Intake at Diagnosis and Risk of Prostate Cancer Progression.

Wilson KM, Mucci LA, Drake BF, Preston MA, Stampfer MJ, Giovannucci E, Kibel AS.

Cancer Prev Res (Phila). 2016 Dec;9(12):933-941. Epub 2016 Sep 20.

30.

Body Mass Index and Metastatic Renal Cell Carcinoma: Clinical and Biological Correlations.

Albiges L, Hakimi AA, Xie W, McKay RR, Simantov R, Lin X, Lee JL, Rini BI, Srinivas S, Bjarnason GA, Ernst S, Wood LA, Vaishamayan UN, Rha SY, Agarwal N, Yuasa T, Pal SK, Bamias A, Zabor EC, Skanderup AJ, Furberg H, Fay AP, de Velasco G, Preston MA, Wilson KM, Cho E, McDermott DF, Signoretti S, Heng DY, Choueiri TK.

J Clin Oncol. 2016 Sep 6. pii: JCO667311. [Epub ahead of print]

31.

Resident Involvement in Radical Inguinal Orchiectomy for Testicular Cancer Does Not Adversely Impact Perioperative Outcomes - A Retrospective Study.

Vetterlein MW, Seisen T, Löppenberg B, Hanna N, Cheng PJ, Fisch M, Chun FK, Kibel AS, Preston MA, Meyer CP.

Urol Int. 2017;98(4):472-477. doi: 10.1159/000448596. Epub 2016 Aug 31.

PMID:
27577733
32.

Retrospective Descriptive Study of an Intensive Care Unit at a Ugandan Regional Referral Hospital.

Ttendo SS, Was A, Preston MA, Munyarugero E, Kerry VB, Firth PG.

World J Surg. 2016 Dec;40(12):2847-2856. doi: 10.1007/s00268-016-3644-5.

PMID:
27506722
33.

Patterns of Recurrence in Upper Tract Transitional Cell Carcinoma: Imaging Surveillance.

Mao Y, Kilcoyne A, Hedgire S, Preston MA, McGovern FJ, Dahl DM, Harisinghani M.

AJR Am J Roentgenol. 2016 Jul 6:1-8. [Epub ahead of print]

PMID:
27382922
34.

Moving Towards Widespread Implementation of Enhanced Recovery Protocols for Radical Cystectomy.

Cheng PJ, Preston MA.

Eur Urol. 2016 Dec;70(6):1004-1005. doi: 10.1016/j.eururo.2016.06.017. Epub 2016 Jun 24. No abstract available.

PMID:
27349613
35.

Baseline Prostate-Specific Antigen Levels in Midlife Predict Lethal Prostate Cancer.

Preston MA, Batista JL, Wilson KM, Carlsson SV, Gerke T, Sjoberg DD, Dahl DM, Sesso HD, Feldman AS, Gann PH, Kibel AS, Vickers AJ, Mucci LA.

J Clin Oncol. 2016 Aug 10;34(23):2705-11. doi: 10.1200/JCO.2016.66.7527. Epub 2016 Jun 13.

36.

Efficacy of High-Intensity Local Treatment for Metastatic Urothelial Carcinoma of the Bladder: A Propensity Score-Weighted Analysis From the National Cancer Data Base.

Seisen T, Sun M, Leow JJ, Preston MA, Cole AP, Gelpi-Hammerschmidt F, Hanna N, Meyer CP, Kibel AS, Lipsitz SR, Nguyen PL, Bellmunt J, Choueiri TK, Trinh QD.

J Clin Oncol. 2016 Oct 10;34(29):3529-3536. doi: 10.1200/JCO.2016.66.7352.

PMID:
27269944
37.

Robot-assisted Versus Open Radical Prostatectomy: A Contemporary Analysis of an All-payer Discharge Database.

Leow JJ, Chang SL, Meyer CP, Wang Y, Hanske J, Sammon JD, Cole AP, Preston MA, Dasgupta P, Menon M, Chung BI, Trinh QD.

Eur Urol. 2016 Nov;70(5):837-845. doi: 10.1016/j.eururo.2016.01.044. Epub 2016 Feb 11.

PMID:
26874806
38.

Primary genitourinary melanoma: Epidemiology and disease-specific survival in a large population-based cohort.

Sanchez A, Rodríguez D, Allard CB, Bechis SK, Sullivan RJ, Boeke CE, Kuppermann D, Cheng JS, Barrisford GW, Preston MA, Feldman AS.

Urol Oncol. 2016 Apr;34(4):166.e7-14. doi: 10.1016/j.urolonc.2015.11.009. Epub 2015 Dec 28.

PMID:
26739672
39.

Comparison of Gonadotropin-Releasing Hormone Agonists and Orchiectomy: Effects of Androgen-Deprivation Therapy.

Sun M, Choueiri TK, Hamnvik OP, Preston MA, De Velasco G, Jiang W, Loeb S, Nguyen PL, Trinh QD.

JAMA Oncol. 2016 Apr;2(4):500-7. doi: 10.1001/jamaoncol.2015.4917.

PMID:
26720632
40.

Diagnosis of Bladder Carcinoma: A Clinician's Perspective.

Harshman LC, Preston MA, Bellmunt J, Beard C.

Surg Pathol Clin. 2015 Dec;8(4):677-85. doi: 10.1016/j.path.2015.07.004. Review.

PMID:
26612221
41.

The Contemporary Incidence and Sequelae of Rhabdomyolysis Following Extirpative Renal Surgery: A Population Based Analysis.

Gelpi-Hammerschmidt F, Tinay I, Allard CB, Su LM, Preston MA, Trinh QD, Kibel AS, Wang Y, Chung BI, Chang SL.

J Urol. 2016 Feb;195(2):399-405. doi: 10.1016/j.juro.2015.08.084. Epub 2015 Aug 28.

PMID:
26321407
42.

Temporal trends in receipt of adequate lymphadenectomy in bladder cancer 1988 to 2010.

Cole AP, Dalela D, Hanske J, Mullane SA, Choueiri TK, Meyer CP, Nguyen PL, Menon M, Kibel AS, Preston MA, Bellmunt J, Trinh QD.

Urol Oncol. 2015 Dec;33(12):504.e9-17. doi: 10.1016/j.urolonc.2015.07.015. Epub 2015 Aug 25.

PMID:
26320810
43.

Role of imaging in testicular cancer: current and future practice.

Barrisford GW, Kreydin EI, Preston MA, Rodriguez D, Harisighani MG, Feldman AS.

Future Oncol. 2015 Sep;11(18):2575-86. doi: 10.2217/fon.15.194. Epub 2015 Aug 28. Review.

PMID:
26314944
44.

Suicide and accidental deaths among patients with non-metastatic prostate cancer.

Dalela D, Krishna N, Okwara J, Preston MA, Abdollah F, Choueiri TK, Reznor G, Sammon JD, Schmid M, Kibel AS, Nguyen PL, Menon M, Trinh QD.

BJU Int. 2016 Aug;118(2):286-97. doi: 10.1111/bju.13257. Epub 2015 Sep 19.

45.

Repurposing a Prokaryotic Toxin-Antitoxin System for the Selective Killing of Oncogenically Stressed Human Cells.

Preston MA, Pimentel B, Bermejo-Rodríguez C, Dionne I, Turnbull A, de la Cueva-Méndez G.

ACS Synth Biol. 2016 Jul 15;5(7):540-6. doi: 10.1021/acssynbio.5b00096. Epub 2015 Aug 10.

PMID:
26230535
46.

Perioperative outcomes after radical cystectomy at NCI-designated centres: Are they any better?

Roghmann F, Ravi P, Hanske J, Meyer CP, Preston MA, Noldus J, Trinh QD.

Can Urol Assoc J. 2015 May-Jun;9(5-6):207-12. doi: 10.5489/cuaj.2621.

47.

Impact of Economic Constraints on Public Health Delivery Systems Structures.

Smith SA, Mays GP, Felix HC, Tilford JM, Curran GM, Preston MA.

Am J Public Health. 2015 Sep;105(9):e48-53. doi: 10.2105/AJPH.2015.302769. Epub 2015 Jul 16.

48.

The Effect of Body Mass Index on Perioperative Outcomes After Major Surgery: Results from the National Surgical Quality Improvement Program (ACS-NSQIP) 2005-2011.

Sood A, Abdollah F, Sammon JD, Majumder K, Schmid M, Peabody JO, Preston MA, Kibel AS, Menon M, Trinh QD.

World J Surg. 2015 Oct;39(10):2376-85. doi: 10.1007/s00268-015-3112-7.

PMID:
26059407
49.

Active surveillance for low-risk prostate cancer: Need for intervention and survival at 10 years.

Preston MA, Feldman AS, Coen JJ, McDougal WS, Smith MR, Paly JJ, Carrasquillo R, Wu CL, Dahl DM, Barrisford GW, Blute ML, Zietman AI.

Urol Oncol. 2015 Sep;33(9):383.e9-16. doi: 10.1016/j.urolonc.2015.04.015. Epub 2015 Jun 6.

PMID:
26059076
50.

The Effect of Resident Involvement on Perioperative Outcomes in Transurethral Urologic Surgeries.

Allard CB, Meyer CP, Gandaglia G, Chang SL, Chun FK, Gelpi-Hammerschmidt F, Hanske J, Kibel AS, Preston MA, Trinh QD.

J Surg Educ. 2015 Sep-Oct;72(5):1018-25. doi: 10.1016/j.jsurg.2015.04.012. Epub 2015 May 21.

PMID:
26003818

Supplemental Content

Loading ...
Support Center